Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Sotac Pharmaceuticals IPO is a book built issue of Rs 33.30 crores. The issue is entirely a fresh issue of 30 lakh shares.
Sotac Pharmaceuticals IPO bidding started from March 29, 2023 and ended on April 3, 2023. The allotment for Sotac Pharmaceuticals IPO was finalized on Monday, April 10, 2023. The shares got listed on NSE SME on April 13, 2023.
Sotac Pharmaceuticals IPO price band is set at ₹105 to ₹111 per share. The minimum lot size for an application is 1200 Shares. The minimum amount of investment required by retail investors is ₹133,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹266,400.
Beeline Capital Advisors Pvt Ltd is the book running lead manager of the Sotac Pharmaceuticals IPO, while Kfin Technologies Limited is the registrar for the issue. The market maker for Sotac Pharmaceuticals IPO is Sunflower Broking.
Refer to Sotac Pharmaceuticals IPO RHP for detailed information.
| IPO Date | March 29, 2023 to April 3, 2023 |
| Listing Date | April 13, 2023 |
| Face Value | ₹10 per share |
| Price Band | ₹105 to ₹111 per share |
| Lot Size | 1200 Shares |
| Total Issue Size | 3,000,000 shares (aggregating up to ₹33.30 Cr) |
| Fresh Issue | 3,000,000 shares (aggregating up to ₹33.30 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Market Maker portion | 150,000 shares Sunflower Broking |
Sotac Pharmaceuticals IPO offers 3,001,800 shares. 571,800 (19.05%) to QIB, 428,400 (14.27%) to NII, 998,400 (33.26%) to RII 853,200 (28.42%) to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | 853,200 (28.42%) |
| Market Maker Shares Offered | 150,000 (5.00%) |
| QIB Shares Offered | 571,800 (19.05%) |
| NII (HNI) Shares Offered | 428,400 (14.27%) |
| Retail Shares Offered | 998,400 (33.26%) |
| Total Shares Offered | 3,001,800 (100%) |
Sotac Pharmaceuticals IPO raises Rs 9.47 crore from anchor investors. Sotac Pharmaceuticals IPO Anchor bid date is March 28, 2023. Sotac Pharmaceuticals IPO Anchor Investors list
| Bid Date | March 28, 2023 |
| Shares Offered | 853,200 |
| Anchor Portion Size (In Cr.) | 9.47 |
| Anchor lock-in period end date for 50% shares (30 Days) | May 10, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | July 9, 2023 |
Sotac Pharmaceuticals IPO opens on March 29, 2023, and closes on April 3, 2023.
| IPO Open Date | Wednesday, March 29, 2023 |
| IPO Close Date | Monday, April 3, 2023 |
| Basis of Allotment | Monday, April 10, 2023 |
| Initiation of Refunds | Tuesday, April 11, 2023 |
| Credit of Shares to Demat | Wednesday, April 12, 2023 |
| Listing Date | Thursday, April 13, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on April 3, 2023 |
Investors can bid for a minimum of 1200 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹133,200 |
| Retail (Max) | 1 | 1200 | ₹133,200 |
| HNI (Min) | 2 | 2,400 | ₹266,400 |
| Lot Size Calculator | |||
Mr. Sharadkumar Dashrathbhai Patel, Mr. Dineshkumar Babulal Gelot, Mr. Vishalkumar Devrajbhai Patel, Mr. Chetankumar Bachubhai Patel, and Mrs. Kiran Baldevbhai Jotania are the promoters of the company.
| Share Holding Pre Issue | 84.63% |
| Share Holding Post Issue |
Incorporated in 2015, Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.
SOTAC is serving over 162 corporate clients on a loan license and/or contract manufacturing basis. With their vast experience in the pharmaceutical segment, the company is growing and enlarging its scale of operations every year.
Sotac Pharmaceuticals established its manufacturing facility in the year 2017. In the year, the company's manufacturing facility was installed with the capacity to manufacture 90 Crore tables/year, and 14 Crore Capsules/year.
With a combined experience of over 59 years in the pharmaceutical manufacturing Industry of the Promoters, the company is blooming and expanding in various horizons.
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Mar-20 | 3,038.21 | 2,882.64 | 8.75 | 305.73 | 75.73 | 15.13 |
| 31-Mar-21 | 3,469.75 | 4,894.97 | -236.54 | 249.36 | 19.36 | 1,035.80 |
| 31-Mar-22 | 3,525.35 | 7,337.02 | 287.86 | 662.19 | 432.19 | 1,134.59 |
| 30-Sep-22 | 6,461.60 | 3,994.65 | 46.55 | 797.41 | 567.41 | 2,185.52 |
| Amount in ₹ Lakhs | ||||||
The market capitalization of Sotac Pharmaceuticals IPO is Rs 122.66 Cr.
| KPI | Values |
|---|---|
| ROE | 6.38% |
| ROCE | 19.03% |
| Debt/Equity | 2.74 |
| Pre IPO | Post IPO | |
|---|---|---|
| P/E (x) | 132.14 |
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
[Dilip Davda] This pharma/healthcare segment company has marked wild fluctuations in its bottom lines for the reported periods. Based on FY23 annualized earnings, the issue appears exorbitantly priced. It is operating in a highly competitive and fragmented segment. SPL’s debt level is also higher and raises concerns. There is no harm in skipping this pricey bet. Read detail review...
The Sotac Pharmaceuticals IPO is subscribed 1.60 times on April 3, 2023 7:30:00 PM. The public issue subscribed 0.91 times in the retail category, 1.00 times in the QIB category, and 4.04 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 1.00 |
| NII | 4.04 |
| Retail | 0.91 |
| Total | 1.60 |
Total Application : 755 (1.30 times)
| Listing Date | April 13, 2023 |
| BSE Script Code | |
| NSE Symbol | SOTAC |
| ISIN | INE0O2D01012 |
| Final Issue Price | ₹111 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| NSE SME |
|---|
| ₹111.00 |
| ₹115.00 |
| ₹115.00 |
| ₹120.75 |
| ₹120.75 |
Sotac Pharmaceuticals Limited
Plot No. PF-21, Nr. ACME Pharma,
Opp. Teva Pharma Sanand GIDC-II,
Sanand Ahmedabad - 382110
Phone: +91 90819 93300
Email: compliance@sotacpharma.com
Website: http://www.sotacpharma.com/
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: sotac.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide 
Sotac Pharmaceuticals IPO is a SME IPO of 3,000,000 equity shares of the face value of ₹10 aggregating up to ₹33.30 Crores. The issue is priced at ₹105 to ₹111 per share. The minimum order quantity is 1200 Shares.
The IPO opens on March 29, 2023, and closes on April 3, 2023.
Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Sotac Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Sotac Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sotac Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sotac Pharmaceuticals IPO opens on March 29, 2023 and closes on April 3, 2023.
Sotac Pharmaceuticals IPO lot size is 1200 Shares, and the minimum amount required is ₹133,200.
You can apply in Sotac Pharmaceuticals IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Sotac Pharmaceuticals IPO will be done on Monday, April 10, 2023, and the allotted shares will be credited to your demat account by Wednesday, April 12, 2023. Check the Sotac Pharmaceuticals IPO allotment status.
IPO Mentor (1100+ Posts, 400+ Likes)
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
IPO Guru (1000+ Posts, 700+ Likes)
Top Contributor (300+ Posts, 100+ Likes)
